Moreover, Ma et al. reported that hypermethylation of the AQP5 promoter in neutrophils from sepsis patients negatively associates with AQP5 expression and protective immune responses, suggesting AQP5 methylation as a candidate biomarker and therapeutic target [28]. This evidence concerns the gene AQP5 and Sepsis.